Scientists offer new clues to genetics of type 2 diabetes

An international collaboration of scientists from Europe and the US has identified six new genes which play a role in the development of type 2 diabetes, extending the total number of genes implicated in common forms of the disease to sixteen.

The findings provide valuable new insights into the mechanisms responsible for the control of sugar levels in the blood and how malfunctions in this mechanism can result in type 2 diabetes. The research, of which the major UK funders were the Wellcome Trust, Medical Research Council, Diabetes UK and the EU, may lead to new ways of treating and preventing diabetes.

The main feature of type 2 diabetes is a sustained abnormal elevation of blood sugar levels. This results from a failure of the systems (involving the production of insulin from the pancreas) which usually keep those levels within tight limits. Exposure to high levels of glucose over years can result in serious damage to the heart, kidneys and other major organs. There are currently over two million people with diabetes in the UK and as many as 750,000 others who have the condition but are unaware.

Ninety researchers from over 40 centres analysed genetic data gathered from over 70,000 people in search of differences in our genetic code that make some people more susceptible than others to type 2 diabetes. Previous work from these groups and others had identified ten genes contributing to type 2 diabetes risk, to which the new findings, published online today in the journal Nature Genetics, add a further six new genes.

“None of the genes we have found was previously on the radar screen of diabetes researchers,” says Professor Mark McCarthy from the University of Oxford, one of the authors of the paper. “Each of these genes therefore provides new clues to the processes that go wrong when diabetes develops, and each provides an opportunity for the generation of new approaches for treating or preventing this condition.”

The research backs up previous studies suggesting that a key process in the development of type 2 diabetes is the failure to regulate the number of insulin-producing cells in the pancreas.

In addition, the researchers have identified a surprising association between type 2 diabetes and the gene known as JAZF1, which has recently been shown to play a role in a very different condition, prostate cancer.

“Genetic studies of this kind are revealing new and unsuspected connections between diseases,” says Dr Eleftheria Zeggini from the University of Oxford, first author on the paper. “This is now the second example of a gene which affects both type 2 diabetes and prostate cancer. We don’t yet know what the connections are, but this has important implications for the future design of drugs for these conditions”.

Each of the new genes only increases the risk of diabetes by a small amount, though when combined, their effects can be more impressive. However, the scientists caution against any immediate rush to use this information to give individual predictions of disease risk.

“Once we more fully understand the large numbers of genes now implicated in diabetes risk, it might become possible to identify people at particularly high risk before the disease takes root,” says Professor David Altshuler of the Broad Institute of Harvard and MIT in Cambridge, USA, who led one of the three groups behind the research. ”However, until we have evidence that using such information results in better health outcomes, widespread genetic testing would be premature.”

The research was made possible through an unprecedented collaborative effort that brought together many groups active in the field of diabetes research. This international collaboration provided access to large data samples, ensuring that the results are robust.

The findings have been welcomed by Professor Simon Howell, Chair of Diabetes UK, which funded the original collection of samples from people with diabetes within the UK.

“It’s remarkable that we still know so little about such a major condition as type 2 diabetes,” says Professor Howell. “By revealing new pathways by which the body normally keeps blood glucose levels under control, this research offers new opportunities for more effective ways of treating and preventing this condition."

Source: Wellcome Trust

Related stories:

A breakthrough, then a surge, in stem cell research
Less than a year after a Wisconsin team helped discover a major alternative to human embryonic stem cells, the Madison scientists say more than 800 labs have begun using the approach, suggesting that many stem-cell researchers are starting to move beyond controversial embryonic sources for their work.
Stem cells from testicles an option to embryos
(AP) -- Cells taken from men's testicles seem as versatile as the stem cells derived from embryos, researchers reported Wednesday in what may be yet another new approach in a burgeoning scientific field.
Sirtris' review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
Sirtris, a GSK company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it published a new review article on the growing body of sirtuin research and its potential to treat diseases of aging such as Type 2 Diabetes, mitochondrial disorders, inflammation, cancer, and heart disease. Entitled "SIRTUINS – Novel Therapeutic Targets to Treat Age-Associated Diseases," the review appears in today's issue of the journal Nature Reviews Drug Discovery.
Important new step toward producing stem cells for human treatment
(PhysOrg.com) -- A team of Harvard Stem Cell Institute (HSCI) scientists has taken an important step toward producing induced pluripotent stem (iPS) cells that are safe to transplant into patients to treat diseases.
Inhibiting cholesterol-associated protein reduces high-risk blockages in arteries
Using the drug darapladib, researchers at the University of Pennsylvania School of Medicine and colleagues have inhibited a cholesterol-and immune system-associated protein, thereby reducing the development of heart-disease plaques that may cause death, heart attacks, and strokes in a pig model of atherosclerosis and diabetes. The study appeared online this week in Nature Medicine.
Type 1 diabetes may result from good genes behaving badly
New research from Stanford University scientists suggests that type 1 diabetes, an autoimmune disease that develops in children and young adults, may not be due to bad genes but rather to good genes behaving badly.
Scientists turn human skin cells into insulin-producing cells
(PhysOrg.com) -- Researchers at the University of North Carolina at Chapel Hill School of Medicine have transformed cells from human skin into cells that produce insulin, the hormone used to treat diabetes.
High levels of physical activity can blunt effect of obesity-related gene, study suggests
High levels of physical activity can help to counteract a gene that normally causes people to gain weight, according to a new study by researchers at the University of Maryland School of Medicine. They analyzed gene variants and activity levels of the Old Order Amish in Lancaster County, Pa., and found that the obesity-related FTO gene had no effect on individuals who were the most physically active.

News discussion:

Medicine & Health news